Prediction of acute myeloid leukaemia risk in healthy individuals
暂无分享,去创建一个
Paolo Vineis | Zhen Zhao | Amos Tanay | Paul Brennan | Eran Segal | Salvatore Panico | Keiran Raine | Matthieu Foll | Ting Ting Wang | Mattias Johansson | Inigo Martincorena | Ran D Balicer | Nicholas J Wareham | Heiner Boeing | Scott V. Bratman | David Jones | Peter J Campbell | Trevor J. Pugh | Omer Weissbrod | Noam Barda | Trevor J Pugh | Elio Riboli | Roel Vermeulen | Stanley W. K. Ng | Sagi Abelson | Elli Papaemmanuil | Shabina Hayat | Kay-Tee Khaw | Liran I. Shlush | John D. McPherson | Moritz Gerstung | Claire Hardy | Mark D Minden | Carlo La Vecchia | Silvia Polidoro | Rui J. Costa | J. McPherson | E. Segal | E. Riboli | P. Campbell | C. Hardy | P. Vineis | R. Vermeulen | C. la Vecchia | A. Tanay | J. Dick | M. Minden | E. Papaemmanuil | David Jones | C. Latimer | K. Raine | T. Pugh | M. Gerstung | I. Martincorena | S. Behjati | N. Wareham | A. Trichopoulou | Karen Ng | L. Heisler | A. Krämer | K. Khaw | R. Balicer | O. Weissbrod | H. Boeing | M. Johansson | R. Kaaks | G. Vassiliou | S. Panico | R. Tumino | S. Polidoro | Lee Timms | P. Brennan | S. Bratman | M. Foll | J. McKay | G. Masala | Sagi Abelson | R. Travis | Y. Sundaravadanam | N. M. Cohen | L. Shlush | A. Karakatsani | Jenna Eagles | Faridah Mbabaali | Jessica K. Miller | Daniel M Pasternack | S. Sieri | J. Quirós | J. Huerta | P. Zuzarte | Jean C. Y. Wang | A. Barricarte | N. Sala | P. Beer | P. Krzyzanowski | S. Hayat | David Soave | P. Awadalla | Rudolf Kaaks | Antonia Trichopoulou | James McKay | Giovanna Masala | Rosario Tumino | G. Collord | E. Niemeyer | Noam Barda | R. Luben | Ting Ting Wang | Zhen Zhao | I. Cirlan | D. Hoult | A. Britten | K. Bowles | E. Salamanca-Fernández | Sabina Sieri | Aurelio Barricarte | Alwin Krämer | Yogi Sundaravadanam | John E. Dick | Lawrence Heisler | Karen Ng | Danielle Pasternack | Lee Timms | Sam Behjati | Calli Latimer | Grace Collord | J Ramón Quirós | Lawrence E. Heisler | Netta Mendelson Cohen | Stanley W.K. Ng | Elisabeth Niemeyer | Philip C. Zuzarte | Robert Luben | Iulia Cirlan | David Soave | Diana Hoult | Abigail Britten | Faridah Mbabaali | Jenna Eagles | Jessica Miller | Paul Krzyzanowski | Phillip Awadalla | Rui Costa | Philip Beer | Jean C.Y. Wang | Kristian M. Bowles | Anna Karakatsani | Elena Salamanca-Fernández | José M. Huerta | Ruth C. Travis | Núria Sala | George S. Vassiliou | Lawrence E Heisler | Calli Latimer | Lee E. Timms | Diana Hoult | Daniel M. Pasternack | J. Mckay | Abigail Britten | Claire W. Hardy | E. Riboli
[1] N E Day,et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.
[2] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.
[3] L. Shlush. Age-related clonal hematopoiesis. , 2018, Blood.
[4] P. Campbell,et al. Somatic mutation in cancer and normal cells , 2015, Science.
[5] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[6] J. Chang-Claude,et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes , 2005, Genetic epidemiology.
[7] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[8] S W Duffy,et al. Clinical Studies , 1877, Journal of Psychological Medicine and Mental Pathology (London, England : 1875).
[9] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[10] Andrew J Vickers,et al. Prediction models in cancer care , 2011, CA: a cancer journal for clinicians.
[11] Suzanna E Lewis,et al. JBrowse: a dynamic web platform for genome visualization and analysis , 2016, Genome Biology.
[12] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[13] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[14] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[15] Brendan F. Kohrn,et al. Detecting ultralow-frequency mutations by Duplex Sequencing , 2014, Nature Protocols.
[16] Keiran M Raine,et al. cgpPindel: Identifying Somatically Acquired Insertion and Deletion Events from Paired End Sequencing , 2015, Current protocols in bioinformatics.
[17] Hui Yang,et al. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR , 2015, Nature Protocols.
[18] Michael Lübbert,et al. Acute myeloid leukemia: Epidemiology and etiology , 2006, Cancer.
[19] D. Qian,et al. A Review of Cancer Risk Prediction Models with Genetic Variants , 2014, Cancer informatics.
[20] I. Weissman,et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.
[21] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[22] Christian Gilissen,et al. Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.
[23] Inigo Martincorena,et al. Precision oncology for acute myeloid leukemia using a knowledge bank approach , 2017, Nature Genetics.
[24] Gary D Bader,et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells , 2017, Nature.
[25] E. Zeggini,et al. Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis , 2015, Cell reports.
[26] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[27] S. Gabriel,et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.
[28] M. Dubé,et al. DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.
[29] Lincoln D. Stein,et al. Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.
[30] S. Miyano,et al. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.
[31] Joshua F. McMichael,et al. Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.
[32] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[33] M. Cabanero,et al. Prognostic value of RDW in cancers: a systematic review and meta-analysis , 2016, Oncotarget.
[34] P. Grambsch,et al. Modeling Survival Data: Extending the Cox Model , 2000 .
[35] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[36] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[37] Zixing Wang,et al. A Bayesian Framework to Improve MicroRNA Target Prediction by Incorporating External Information , 2014, Cancer informatics.
[38] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[39] John O'Quigley,et al. Explained randomness in proportional hazards models , 2005, Statistics in medicine.
[40] G. Vassiliou,et al. Aging as a driver of leukemogenesis , 2015, Science Translational Medicine.
[41] R. Balicer,et al. Digital health nation: Israel's global big data innovation hub , 2017, The Lancet.
[42] P. Campbell,et al. VAGrENT: Variation Annotation Generator , 2015, Current protocols in bioinformatics.
[43] M. Stratton,et al. High burden and pervasive positive selection of somatic mutations in normal human skin , 2015, Science.
[44] M. Gerstung,et al. Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.
[45] Mario Cazzola,et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.
[46] D. Gilliland,et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. , 1996, Blood.
[47] L. Bullinger,et al. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. , 2013, Blood.
[48] Ran D Balicer,et al. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study , 2017, British Medical Journal.
[49] Ash A. Alizadeh,et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.